Monitoring measurable residual disease and chimerism in patients with JAK2 V617F-positive myelofibrosis after allogeneic hematopoietic cell transplantation

por Lee, Jong-Mi, Ahn, Ari, Min, Eun Jeong, Lee, Sung-Eun, Kim, Myungshin, Kim, Yonggoo
Publicado 2023

Clinical, Laboratory, and Bone Marrow Findings of 31 Patients With Waldenström Macroglobulinemia

por Ahn, Ari, Park, Chan-Jeoung, Cho, Young-Uk, Jang, Seongsoo, Seo, Eul-Ju, Lee, Jung-Hee, Yoon, Dok Hyun, Suh, Cheolwon
Publicado 2020

FLT3-ITD Measurable Residual Disease Monitoring in Acute Myeloid Leukemia Using Next-Generation Sequencing

por Lee, Jong-Mi, Park, Silvia, Hwang, Insik, Kang, Dain, Cho, Byung Sik, Kim, Hee-Je, Ahn, Ari, Kim, Myungshin, Kim, Yonggoo
Publicado 2022

Clinical implication of minimal residual disease assessment by next-generation sequencing-based immunoglobulin clonality assay in pediatric B-acute lymphoblastic leukemia

por Lee, Jae Wook, Kim, Yonggoo, Ahn, Ari, Lee, Jong Mi, Yoo, Jae Won, Kim, Seongkoo, Cho, Bin, Chung, Nack-Gyun, Kim, Myungshin
Publicado 2022

Multiple Myeloma in a Patient with Acromegaly

por Kang, Yu Mi, Choi, Jong Han, Lee, Min Jung, Ahn, Ari, Park, Chan-Jeoung, Chang, Kiju, Seo, Seyoung, Hong, Sun In, Kim, Min-Seon
Publicado 2015

Discontinuation of tyrosine kinase inhibitors based on BCR-ABL1 monitoring by digital droplet PCR in pediatric chronic myeloid leukemia

por Kim, Yeojae, Kim, Seongkoo, Lee, Jong Mi, Ahn, Ari, Yoo, Jae Won, Lee, Jae Wook, Cho, Bin, Chung, Nack-Gyun, Kim, Yonggoo, Kim, Myungshin
Publicado 2022

Spectrum of Genetic Mutations in Korean Pediatric Acute Lymphoblastic Leukemia

por Yoo, Jae Won, Ahn, Ari, Lee, Jong-Mi, Jo, Suejung, Kim, Seongkoo, Lee, Jae Wook, Cho, Bin, Kim, Yonggoo, Kim, Myungshin, Chung, Nack-Gyun
Publicado 2022

Two Rare Cases of Therapy-Related Acute Lymphoblastic Leukemia in Patients With Plasma Cell Myeloma

por Lee, Hye-Young, Park, Chan-Jeoung, Ahn, Ari, Lee, Min Yung, Cho, Young-Uk, Jang, Seongsoo, Seo, Eul-ju, Lee, Kyoo-Hyung, Lee, Je-Hwan
Publicado 2019

Genetic and Clinical Characteristics of Korean Chronic Lymphocytic Leukemia Patients with High Frequencies of MYD88 Mutations

por Ahn, Ari, Kim, Hoon Seok, Kim, Tong-Yoon, Lee, Jong-Mi, Kang, Dain, Yu, Haein, Lee, Chae Yeon, Kim, Yonggoo, Eom, Ki-Seong, Kim, Myungshin
Publicado 2023

Perspectives on acute myeloid leukemia diagnosis: a comparative analysis of the latest World Health Organization and the International Consensus Classifications

por Jung, Jin, Kwag, Daehun, Kim, Yonggoo, Lee, Jong-Mi, Ahn, Ari, Kim, Hoon Seok, Bae, Byunggyu, Park, Silvia, Kim, Hee-Je, Cho, Byung-Sik, Kim, Myungshin
Publicado 2023

Genetic Characteristics According to Subgroup of Acute Myeloid Leukemia with Myelodysplasia-Related Changes

por Kang, Dain, Jung, Jin, Park, Silvia, Cho, Byung-Sik, Kim, Hee-Je, Kim, Yeojae, Lee, Jong-Mi, Kim, Hoon Seok, Ahn, Ari, Kim, Myungshin, Kim, Yonggoo
Publicado 2022

Granulocytic and Monocytic Myeloid-Derived Suppressor Cells are Functionally and Prognostically Different in Patients with Chronic Myeloid Leukemia

por Ahn, Ari, Park, Chan-Jeoung, Kim, Min-sun, Cho, Young-Uk, Jang, Seongsoo, Bae, Mi Hyun, Lee, Jung-Hee, Lee, Je-Hwan, Koh, Kyung-Nam, Im, Ho Joon
Publicado 2021

Advantage of achieving deep response following frontline daratumumab-VTd compared to VRd in transplant-eligible multiple myeloma: multicenter study

por Byun, Ja Min, Park, Sung-Soo, Yoon, Sung-Soo, Ahn, Ari, Kim, Myungshin, Lee, Jung Yeon, Jeon, Young-Woo, Shin, Seung-Hwan, Yahng, Seung-Ah, Koh, Youngil, Min, Chang-Ki
Publicado 2023